chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Swollen armpit; This spontaneous case was reported by a pharmacist and describes the occurrence of LYMPHADENOPATHY (Swollen armpit) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Feb-2022, the patient experienced LYMPHADENOPATHY (Swollen armpit). At the time of the report, LYMPHADENOPATHY (Swollen armpit) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported.  Patient received the booster on Thursday.  No treatment medication was reported.   Reporter did not allow further contact
hours later fever, chill, h/a, redness @ site followed by diarrhea;T100 2 days;today is afeb, diarrhea is ending;no chills or h/a;arm is red, hard & hot;area 4" x 6" center area 1 1/2" in diameter red, purple, ready to ooze;
got first dose a year and a half before 2nd dose; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in a 72-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st received a year and a half before).   On 06-NOV-2023, the patient received the 2nd dose of Shingrix. On 06-NOV-2023, an unknown time after receiving Shingrix, the patient experienced drug dose administration interval too long (Verbatim: got first dose a year and a half before 2nd dose). The outcome of the drug dose administration interval too long was unknown.   Additional Information: GSK receipt date: 06-NOV-2023 The pharmacist mentioned that a patient got first dose of Shingrix a year and a half before and 2nd dose. The patient received 2nd dose of Shingrix, later than the recommended interval, which led to lengthening of vaccinations schedule. (Drug dose administration interval too long) plus 7 days. The reporter consented to follow up.
Mild chills; Light headedness; The patient received 5th dose of Comirnaty; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 62-year-old male patient received BNT162b2 (BNT162B2), on 08Sep2022 at 11:00 as dose 5 (booster), single (Lot number: GH9694) at the age of 62 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Depression" (unspecified if ongoing). Concomitant medication(s) included: TYPHOID taken for immunisation, on 01Sep2022 as dose number unknown, single; TDAP taken for immunisation, on 31Aug2022 as dose number unknown, single; HEPATITIS A VACCINE;HEPATITIS B VACCINE taken for immunisation, on 01Sep2022 as dose number unknown, single; ELIQUIS; LAMOTRIGINE; CLONAZEPAM; QUETIAPINE. Past drug history included: On blood thinner (eliquis), notes: on blood thinner (Eliquis). Vaccination history included: Covid-19 vaccine (DOSE 1, MANUFACTURER UNKNOWN), for COVID-19 immunization; Covid-19 vaccine (DOSE 2, MANUFACTURER UNKNOWN), for COVID-19 immunization; Covid-19 vaccine (DOSE 3 (BOOSTER), MANUFACTURER UNKNOWN), for COVID-19 immunization; Covid-19 vaccine (DOSE 4 (BOOSTER), MANUFACTURER UNKNOWN), for COVID-19 immunization. The following information was reported: INCORRECT DOSE ADMINISTERED (non-serious) with onset 08Sep2022 at 11:00, outcome "unknown", described as "The patient received 5th dose of Comirnaty"; DIZZINESS (non-serious) with onset 08Sep2022 at 12:00, outcome "not recovered", described as "Light headedness"; CHILLS (non-serious) with onset 08Sep2022 at 12:00, outcome "not recovered", described as "Mild chills". Therapeutic measures were not taken as a result of chills, dizziness.  Additional information: Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient received other vaccines within 4 weeks prior to the vaccination. The patient did not have any known allergies.
Lethargy noted p/shot; Awoke @ 5AM, thirsty given liquid; family noticed pt was warm; temp not taken; 6AM pt found w/eyes rolled back & shaking; Did not respond to verbal stimuli, but cried & moved extremities; Incontinence urine & LOC;t103
Left arm: little soreness, little itch, swelling at injection site approx 2 inches wd.
Arms and hands started shaking 15 minutes later. Started sweating, started at 4:00ish. BP elevated, increased temp. Seen ER - BENADRYL given IV helped.
Information has been received from the VAERS database via a journalist. This spontaneous report refers to a patient of unknown age. The patient was vaccinated with lot # (659406/0298X) ZOSTAVAX on 09-JUN-2008. No other co-suspects were reported. No concomitant medications were reported. On an unknown date the patient experienced herpes zoster. No treatment information was reported. The outcome of herpes zoster is unknown. the relatedness for herpes zoster is unknown for ZOSTAVAX. Additional information is not expected.
Shingles; painful welts appearing on left arm the day following 2nd vaccine. Started with 2 welts. Swelling and more shingles appearing over the following days on left arm. Additional rash appearing on left-side and back. Occurred throughout most of May 2021. Multiple doctor appointments, then dermatology appointments for diagnosis of shingles.
Patient was given Moderna Booster 0.25ml around 5:00pm on Saturday 04/16/2022 into the left deltoid. He was given his Vaccine Card around 5:15pm. Patient was feeling fine. Patient returned to the pharmacy around 5:50pm concerned about a rash on his left forearm. He was breathing and feeling fine. No itching, just reddish patches on the arm. (2 large ones about 3inches in length, 1.5 inches wide) Patient was given 25mg of Diphenhydramine Oral solution (10ml). He was asked to have a seat to be monitored further. The rash went away within 20 minutes of the diphenhydramine dose. Patient was ready to leave. He said he felt fine.
My blood/glucose level was abnormally high for two days following the vaccine My diabetes symptoms were more prevalent( thirst, frequent urination, dry mouth, diarrhea)
No rash or blisters BUT extreme pain to the touch around my whole midriff; doctors described it as shingles like symptoms and I am still suffering although with my new medication IT IS BETTER.
Wrist joint pain (both wrists), neck pain, shoulder joint pain, TINNITUS.
Hives, diffuse over body. Intense itching on hands, legs, stomach, scalp, chest, and neck. Would welt up then disappear and then reappear. Start time 3:00pm 2/5/21 and is ongoing. Antihistamines and IM 4mg decadron shot taken. Helped for a time but symptoms have proceeded.
After 2nd dose, anxiety got worse; Her back would tighten; Her neck and chest would feel achy; Her neck and chest would feel achy; Any kind of physical exercise is exhausting as of now; This spontaneous case was reported by a consumer and describes the occurrence of ANXIETY (After 2nd dose, anxiety got worse), MUSCULOSKELETAL DISCOMFORT (Her back would tighten), NECK PAIN (Her neck and chest would feel achy), CHEST PAIN (Her neck and chest would feel achy) and FATIGUE (Any kind of physical exercise is exhausting as of now) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 023B21A and 044B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included PIROXICAM (PAXIL [PIROXICAM]) for an unknown indication.   On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ANXIETY (After 2nd dose, anxiety got worse), MUSCULOSKELETAL DISCOMFORT (Her back would tighten), NECK PAIN (Her neck and chest would feel achy), CHEST PAIN (Her neck and chest would feel achy) and FATIGUE (Any kind of physical exercise is exhausting as of now). The patient was treated with PIROXICAM (PAXIL [PIROXICAM]) for Adverse event, at a dose of 1 dosage form. At the time of the report, ANXIETY (After 2nd dose, anxiety got worse), MUSCULOSKELETAL DISCOMFORT (Her back would tighten), NECK PAIN (Her neck and chest would feel achy), CHEST PAIN (Her neck and chest would feel achy) and FATIGUE (Any kind of physical exercise is exhausting as of now) outcome was unknown.            No lab data was provided by the reporter.   This case was linked to MOD-2021-234367 (Patient Link).
Skin flushed red on hands and arms, blotchy red spots on same.dizzy, felt like had a vise around head. Started sneezing and increased congestion. Within 15minutes of shot.
P.A.N.D.A.S. - crazy psychiatric behavior, terrible tics, stutter, out of school for one year - learning disabilities - weight loss, impossible situation.
This spontaneous report as received from a 30 year old nursing student regarding herself who was possibly allergic to anesthesia. Pertinent medical history was none. On 19-JUN-2013, the patient went to her physician's office to receive Dose 2 of VARIVAX (Merck) (Lot number was not reported, expired date 14-JUN-2013, dose was not reported) subcutaneously in the arm. After it was administered the office nurse realized the dose had already expired. When the office nurse realized the VARIVAX (Merck) was expired, she administered another dose of VARIVAX (Lot number, expiry date and dose were not reported) which was not expired during the same visit but in the nursing student's opposite arm subcutaneously. Concomitant therapies included NUVARING. Approximately on 20-JUN-2013 (reported as the following day), the patient developed hives at the injection site of both arms that were round, raised, itchy and hot to the touch. The patient sought medical attention, went to a clinic and was prescribed prednisone, hydroxyzine, and BENADRYL. The patient mentioned that she had also received a Purified Protein Derivative (PPD) test on 19-JUN-2013, prior to receiving VARIVAX (Merck). She was told by the clinic not to start the medications until after she received the results of her PPD test. Lab diagnostic test performed was none. Currently the injection site areas were not raised but were sometimes itchy. The patient also stated that when she received first dose of VARIVAX (Merck) on an unspecified date, she did not have any adverse symptoms. The event developed hives at the injection site of both arms that were round, raised, itchy and hot to the touch was reported as recovering/resolving. Legal issue was involved and the adverse event was sent to legal team. Additional information has been requested.
Information has been received from a registered nurse referring to a 13 year old patient of unknown gender. On 16-JUL-2015 the patient was vaccinated with GARDASIL (lot # K006960, intramuscular, expiration date and dose were unknown) which excursed the storage temperature (incorrect product storage). No reaction was reported. This is one of several reports received from the same reporter. Additional information has been requested.
No adverse effects; one separate dose of an improperly stored vaccine, PEDVAXHIB was administered to one separate patient.; Information has been received from a medical assistant, referring to a patient of unknown age and gender. Information of concomitant therapy, pertinent medical history and drug reactions/allergies was not reported.    On 07-MAY-2019, the patient was vaccinated with improperly stored haemophilus b conjugate vaccine (meningococcal protein conjugate)(LIQUID PEDVAXHIB) 0.5 milliliter (one dose, lot # R013573, expiration date: 22-MAR-2021, frequency was unknown) intramuscularly for prophylaxis (incorrect product storage). No adverse effect was reported.  The vaccines were exposed to temperature of 34.2 Fahrenheit (F) for 4 hour 54 minutes. The temperature excursion was detected by a data logger. No previous excursions were reported.  This is one of several reports from the same reporter.; Sender's Comments:  US-009507513-1907USA000998: US-009507513-1907USA000999: US-009507513-1907USA001000: US-009507513-1907USA001001: US-009507513-1907USA001002: US-009507513-1907USA001003: US-009507513-1907USA001004: US-009507513-1907USA001005: US-009507513-1907USA001006: US-009507513-1907USA001007: US-009507513-1907USA001008: US-009507513-1907USA001009: US-009507513-1907USA001010: US-009507513-1907USA001011: US-009507513-1907USA001012: US-009507513-1907USA001013: US-009507513-1907USA001014: US-009507513-1907USA001015: US-009507513-1907USA001016: US-009507513-1907USA001017: US-009507513-1907USA001018: US-009507513-1907USA001019: US-009507513-1907USA001020: US-009507513-1907USA001021: US-009507513-1907USA001022: US-009507513-1907USA001023: US-009507513-1907USA001024: US-009507513-1907USA001025: US-009507513-1907USA001026: US-009507513-1907USA001027: US-009507513-1907USA001028: US-009507513-1907USA001029: US-009507513-1907USA001030: US-009507513-1907USA001031: US-009507513-1907USA001032: US-009507513-1907USA001033: US-009507513-1907USA001034: US-009507513-1907USA001035: US-009507513-1907USA001036: US-009507513-1907USA001037: US-009507513-1907USA001038: US-009507513-1907USA001039: US-009507513-1907USA001040: US-009507513-1907USA001041: US-009507513-1907USA001042: US-009507513-1907USA001043: US-009507513-1907USA001044: US-009507513-1907USA001045: US-009507513-1907USA001046: US-009507513-1907USA001047: US-009507513-1907USA001048: US-009507513-1907USA001049: US-009507513-1907USA001050: US-009507513-1907USA001051: US-009507513-1907USA001052: US-009507513-1907USA001053: US-009507513-1907USA001054: US-009507513-1907USA001055: US-009507513-1907USA001056: US-009507513-1907USA001057: US-009507513-1907USA001058: US-009507513-1907USA000862:
R arm swollen, red, painful s/p vaccine. Pt c/o body chills and headache s/p vaccine.
Upon waking up Saturday 11/12/22 @ 8 am. Body aches in joints and especially in right knee which I suffer injury years ago.  I didn't notice swollen in the beginning. I kept resting and hopefully it will pass. Went to my dentist visit.  Tuesday morning, the pain became worse. Tried elevating my leg and put icepack.
Sudden onset of decreased sensation and tingling in right cheek and upper lip. Felt like face "went to sleep". Symptoms lasted 2-3 weeks. Developed new neurological symptoms in 6/07 after AVA. Dx'ed with MS in 9/07.
14MAY felt sick & had h/a;15MAY t103, vomiting cont;16MAY taken to ER 8AM t39C;petechiae on face & chin given IV fluids, blood count 20,000 WBC;APAP given;went home @ noon;t99.4 orally
mom reported vomiting over 3-4 hrs period approx 5-6 hrs p/vax;
This spontaneous report as received from a registered nurse refers to an unspecified number of unspecified patients of unknown age. On an unknown date the patient was vaccinated with GARDASIL (lot number, dose, route and indication were not provided). The nurse reported that GARDASIL had been stored in the original box at temperatures between 2C to 8C, however, the lid of the GARDASIL box had been removed. GARDASIL had been exposed to an unspecified amount of light for an unspecified amount of time when the refrigerator door was periodically opened. This GARDASIL had been administered to an unspecified number of unspecified patients on unspecified dates. No adverse effects reported. The outcome and action taken were not provided. It was unspecified if the patient sought any medical attention. Additional information has been requested.
pt presented w/rash on the chest & abdomen following 1st wk following MMR vax; MMR given 19MAR92 rash started 26MAR; t38C on 26MAR; by 3rd wk rash had spread to entire body x/face;
This spontaneous report as received from a pharmacist via another pharmacist refers to a currently 73 years old female patient with no drug reactions/allergies. On an unspecified day in August 2008 the patient was vaccinated with a 0.65 ml dose of ZOSTAVAX, subcutaneously. There was no concomitant medication. On an unknown date the patient developed shingles after the vaccine. The pharmacist reported that the patient developed the shingles infection in her mouth and had to be fed through a straw for an unspecified amount of time. The patient sought medical attention by going to physician office for a visit on an unspecified day. The outcome of shingles infection in her mouth was reported as recovered/resolved. Additional information has been requested.
She has had recurrent headaches and fatigue since receiving the second dose. Has also had several URI type illnesses. Prior to the vaccine, she was never in the office for sick visits and reportedly never got sick. She did not have history of headaches either.
arm pain; headache; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (arm pain) and HEADACHE (headache) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced MYALGIA (arm pain) and HEADACHE (headache). At the time of the report, MYALGIA (arm pain) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. No treatment information provided.
Several hours after receiving the pneumonia shot patient complained of soreness in the injection site and redness & swelling on the upper right arm. The area is warm to touch and is sore. PCP has been contacted. Red and swollen area has spread to entire inner upper arm area 48 hours after injection. MD recommended ice packs and BENADRYL.
tested COVID19 positive; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of SARS-COV-2 TEST POSITIVE (tested COVID19 positive) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, the patient experienced SARS-COV-2 TEST POSITIVE (tested COVID19 positive). At the time of the report, SARS-COV-2 TEST POSITIVE (tested COVID19 positive) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Feb-2021, SARS-CoV-2 test positive: positive positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
The patient developed mild swelling and redness developing over 2 days extending from below the injection site down approximately 4-6 inches.  She went to urgent care for evaluation.  The provider ruled out allergic-type reaction, recommended topical Benadryl cream and redness and swelling went down within 24 hours.
Developed  rash nine or ten days after the shot at the shot site and very slight soreness more like a tenderness.  Currently still have it, it's been  four or five days since first noticed.  don't remember if I first saw it on Feb 20, or 21st .
MD notified @ home from ER-parents heard pt gasp-pt having sz-pt taken to ER where died;
a couple of hr p/vax called said woke up w/shrill, high pitched cry, pale some consolation when held but resumed shrill high pitched cry if disturbed lasted less than 2hr;
PNEUMONIA; ATTACK OF DIVERTICULITUS; SHOT DID NOT WORK; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age, sex, race and ethnicity. The patient's height, and weight were not reported. The patient's concurrent conditions included: chronic obstructive pulmonary disease (COPD), and peripheral arterial disease (PAD). The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown expiry: Unknown) with unknown dose, 1 total, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the patient went to hospital and had an attack of diverticulitis. Further patient underwent Scan and diagnosed with pneumonia. The patient experienced shot did not work. Patient believed since patient got the vaccine patient's lungs and breathings had been better.  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the pneumonia, attack of diverticulitus and shot did not work was not reported.  This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20211033699-COVID-19 VACCINE AD26.COV2.S-Attack of diverticulitus. This event(s) is considered unassessable. The event(s) has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). 20211033699-COVID-19 VACCINE AD26.COV2.S-Pneumonia. This event(s) is considered not related. The event(s) has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: MEDICAL HISTORY 20211033699-COVID-19 VACCINE AD26.COV2.S-Shot did not work. This event is considered not related. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event than the drug. Specifically: SPECIAL SITUATIONS
The moment needle was in right deltoid, pt started to waver w/eyes rolling back.  Pt began to wobble to a fro.  I helped him to his seat.  Water was given.  He stayed around for 15-20 minutes and he left stating that he was feeling okay.
Narrative: COVID infection following COVID vaccine series 01/14, Pfizer, dose #2 02/04, Pfizer, dose #2 08/06 COVID swab, result: detected 08/06 pt cc: unknown exposure: unknown
Ipsilateral (to side of vaccination, i.e. left)  supraclavicular adenopathy (painful, swollen, very tender to palpation for 3 days) Itchy throat Congestion Left arm soreness (this was immediately after, resolved after 3 days around the time the adenopathy began)
Site: Bruising at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Joint Pain-Medium, Additional Details: Patient received Moderna Dose 1 on 5/8/21 at cvs 17128 and has been experiencing pain in the arm, bruising, swelling and a stiff neck. As a result he will be seeing his doctor on 5/26/21
Day after receiving KINRIX, MMR II, VARIVAX, developed fever, back pain, hives.
both legs swollen p/vax; cool packs & baking soda cool packs;
1 of 3 pts who recvd 1st dose of pnu-imune & devel swelling of approx 3 inches in diameter @ the inject site; resolved-no treatment initiated;
Pt experiened fever(100F), chills and swollen lymph nodes. Vaccine was administered as PEP for exposure to positive MPOX case 7 days prior. Pt pending testing for MPOX as symptoms are also compatible with that.
A few days after shot 4/27/21- went to ER hospital, with leg, body spasms, could barely talk, shaking uncontrollable - just awful never saw anything like it before.  They did blood test and cat scan of head and couldn't find anything so referred her to neurologist -- waiting to get appt.  We forgot to tell them that she had 2nd cover shot on the 22.  Didn't even think of that then.  They would not admit her.  I had to take her home shaking but they did give her some divan at hospital which helped some.